This company has been marked as potentially delisted and may not be actively trading. Imago BioSciences (IMGO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IMGO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period RA Capital-backed startup raises $100M; UCB sells China businessAugust 28, 2024 | finance.yahoo.comAvidity Biosciences Stock (NASDAQ:RNA), Analyst Ratings, Price Targets, PredictionsMay 4, 2024 | benzinga.comImago Theatre aims to find out if time-traveling Neanderthals have answers to climate changeApril 13, 2024 | msn.comMerck: Better Times Ahead On Approvals And OutlookApril 2, 2024 | seekingalpha.comClarus Lifesciences III, L.P.'s Net WorthFebruary 23, 2024 | benzinga.comAnixa Biosciences Inc ANIXDecember 21, 2023 | morningstar.comMHarmony Biosciences shares are trading lower after the company reported Q4 financial results.February 23, 2023 | benzinga.comMerck To Complete Acquisition Of ImagoJanuary 11, 2023 | markets.businessinsider.comMerck Completes Tender Offer to Acquire Imago BioSciences, Inc.January 11, 2023 | finance.yahoo.comImago BioSciences (Nasdaq:IMGO) HeadlineTrading was temporarily halted for "IMGO" at 07:01 PM with a stated reason of "News pending."...January 11, 2023 | marketbeat.comLooking Into Imago BioSciences's Recent Short InterestJanuary 4, 2023 | msn.comMerck is best performing large U.S. pharma of 2022December 30, 2022 | seekingalpha.comLaura G. Eichorn Sells 3,100 Shares of Imago BioSciences, Inc. (NASDAQ:IMGO) StockDecember 29, 2022 | marketbeat.comImago BioSciences, Inc. (NASDAQ:IMGO) Given Average Recommendation of "Hold" by AnalystsDecember 23, 2022 | marketbeat.comImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in MyelofibrosisDecember 20, 2022 | finance.yahoo.comImago BioSciences, Inc. (NASDAQ:IMGO) Insider Jennifer Peppe Sells 119,422 SharesDecember 19, 2022 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, USERDecember 13, 2022 | markets.businessinsider.comImago BioSciences, Inc. (NASDAQ:IMGO) Short Interest Down 79.4% in NovemberDecember 12, 2022 | marketbeat.comImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022December 12, 2022 | finance.yahoo.comImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022December 12, 2022 | finance.yahoo.comMerck Commences Tender Offer To Acquire Imago BioSciencesDecember 12, 2022 | markets.businessinsider.comHow Is The Market Feeling About Imago BioSciences?December 9, 2022 | msn.comImago BioSciences: The Bone Marrow Cancer Researcher Reaches MilestoneNovember 30, 2022 | seekingalpha.comImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid LeukemiaNovember 30, 2022 | finance.yahoo.comHorizon Therapeutics Fields Takeover Interest From Pharma GiantsNovember 29, 2022 | finance.yahoo.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Imago BioSciences, Inc. - IMGONovember 28, 2022 | benzinga.comAnalyst Ratings for Imago BioSciencesNovember 28, 2022 | markets.businessinsider.comImago BioSciences (NASDAQ:IMGO) Lowered to Hold at Stifel NicolausImago BioSciences (NASDAQ:IMGO) Lowered to Hold at Stifel Nicolaus...November 28, 2022 | marketbeat.comPharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New IndicationNovember 25, 2022 | finance.yahoo.comImago Bio Shares Soar on Agreement to Selll to Merck for $1.35 Billion CashNovember 24, 2022 | 247wallst.comImago BioSciences, Inc. (NASDAQ:IMGO) Forecasted to Post Q2 2023 Earnings of ($0.63) Per ShareNovember 24, 2022 | marketbeat.comImago BioSciences, Inc. Expected to Post Q1 2023 Earnings of ($0.57) Per Share (NASDAQ:IMGO)Imago BioSciences, Inc. Expected to Post Q1 2023 Earnings of ($0.57) Per Share (NASDAQ:IMGO)...November 23, 2022 | marketbeat.comExpert Ratings for Imago BioSciencesNovember 22, 2022 | markets.businessinsider.comWhat 5 Analyst Ratings Have To Say About Imago BioSciencesNovember 22, 2022 | markets.businessinsider.comImago (IMGO) Shares Surge 104% on Buyout Offer From MerckNovember 22, 2022 | finance.yahoo.comImago BioSciences' (IMGO) "Neutral" Rating Reaffirmed at HC WainwrightImago BioSciences' (IMGO) "Neutral" Rating Reaffirmed at HC Wainwright...November 22, 2022 | marketbeat.comMerck Eyes Expanded Blood Disorder Drug Pipeline Via $1.35 Billion Buyout of Imago BioSciencesNovember 21, 2022 | msn.comCancer-Focused Imago BioSciences Shares Soar After Merck DealNovember 21, 2022 | finance.yahoo.comImago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesNovember 21, 2022 | ca.finance.yahoo.comMerck to Buy Imago, Shares GainNovember 21, 2022 | baystreet.caDisney, Imago BioSciences rise premarket; Coinbase, Carvana fallNovember 21, 2022 | msn.comImago BioSciences Shares Take Flight on Takeover by Merck >IMGONovember 21, 2022 | marketwatch.comIMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to ShareholdersNovember 21, 2022 | technews.tmcnet.comMerck to buy Imago Biosciences for $1.35 billionNovember 21, 2022 | finance.yahoo.comImago BioSciences Stock Surges. It’s Being Bought by Merck.November 21, 2022 | finance.yahoo.comImago BioSciences Catapults To Record High On Merck's $1.35 Billion BuyoutNovember 21, 2022 | finance.yahoo.comImago BioSciences, Inc. (NASDAQ:IMGO) Forecasted to Earn FY2022 Earnings of ($1.94) Per ShareNovember 14, 2022 | marketbeat.comImago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesNovember 9, 2022 | finance.yahoo.comAmy E. Tapper Sells 750 Shares of Imago BioSciences, Inc. (NASDAQ:IMGO) StockNovember 4, 2022 | marketbeat.comImago BioSciences Announces Oral Data Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and ExpositionNovember 3, 2022 | finance.yahoo.com Get Imago BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IMGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMGO Media Mentions By Week IMGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMGO News Sentiment▼0.000.63▲Average Medical News Sentiment IMGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMGO Articles This Week▼00▲IMGO Articles Average Week Get the Latest News and Ratings for IMGO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Imago BioSciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MENS News MOR News ZYME News MBX News AVTE News BIOA News CYBN News VIRI News ELYM News OSTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMGO) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imago BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imago BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
